289 related articles for article (PubMed ID: 15239218)
1. No prognostic significance of antimitochondrial antibody profile testing in primary biliary cirrhosis.
Vleggaar FP; van Buuren HR
Hepatogastroenterology; 2004; 51(58):937-40. PubMed ID: 15239218
[TBL] [Abstract][Full Text] [Related]
2. Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis?
Joshi S; Cauch-Dudek K; Heathcote EJ; Lindor K; Jorgensen R; Klein R
Am J Gastroenterol; 2002 Apr; 97(4):999-1002. PubMed ID: 12003438
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis.
Invernizzi P; Crosignani A; Battezzati PM; Covini G; De Valle G; Larghi A; Zuin M; Podda M
Hepatology; 1997 May; 25(5):1090-5. PubMed ID: 9141422
[TBL] [Abstract][Full Text] [Related]
4. [The value of antimitochondrial antibody and its subtypes in the diagnosis of primary biliary cirrhosis].
Yao DK; Xie WF; Chen WZ; Liu HY; Tu XQ; Fan LY
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):9-11. PubMed ID: 15670482
[TBL] [Abstract][Full Text] [Related]
5. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
[TBL] [Abstract][Full Text] [Related]
6. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
[TBL] [Abstract][Full Text] [Related]
7. Clinical correlation of antimitochondrial antibodies.
Zuber MA; Recktenwald C
Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic features of primary biliary cirrhosis in AMA-positive and AMA-negative patients.
Fujioka S; Yamamoto K; Okamoto R; Miyake M; Ujike K; Shimada N; Terada R; Miyake Y; Nakajima H; Piao CY; Iwasaki Y; Tanimizu M; Tsuji T
Endoscopy; 2002 Apr; 34(4):318-21. PubMed ID: 11932789
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis.
Zhang FK; Jia JD; Wang BE
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):288-91. PubMed ID: 15138128
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic significance of antimitochondrial antibody profiles A-D in primary biliary cirrhosis].
Klein R; Berg PA
Dtsch Med Wochenschr; 1988 Oct; 113(40):1549-53. PubMed ID: 3168779
[TBL] [Abstract][Full Text] [Related]
11. [Immunological characteristics of primary biliary cirrhosis patients].
Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
[TBL] [Abstract][Full Text] [Related]
12. Primary biliary cirrhosis and hepatitis C virus infection.
Floreani A; Baragiotta A; Leone MG; Baldo V; Naccarato R
Am J Gastroenterol; 2003 Dec; 98(12):2757-62. PubMed ID: 14687829
[TBL] [Abstract][Full Text] [Related]
13. When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?
Zein CO; Angulo P; Lindor KD
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):89-95. PubMed ID: 15017500
[TBL] [Abstract][Full Text] [Related]
14. Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis.
Rigopoulou EI; Davies ET; Bogdanos DP; Liaskos C; Mytilinaiou M; Koukoulis GK; Dalekos GN; Vergani D
Liver Int; 2007 Nov; 27(9):1226-31. PubMed ID: 17919234
[TBL] [Abstract][Full Text] [Related]
15. Detection of novel non-M2-related antimitochondrial antibodies in patients with anti-M2 negative primary biliary cirrhosis.
Feuchtinger M; Christ S; Preuss B; Dengjel J; Duman S; Stevanovic S; Klein R
Gut; 2009 Jul; 58(7):983-9. PubMed ID: 19336422
[TBL] [Abstract][Full Text] [Related]
16. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens.
Miyakawa H; Tanaka A; Kikuchi K; Matsushita M; Kitazawa E; Kawaguchi N; Fujikawa H; Gershwin ME
Hepatology; 2001 Aug; 34(2):243-8. PubMed ID: 11481607
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and longterm course of primary biliary cirrhosis in primary Sjögren's syndrome.
Hatzis GS; Fragoulis GE; Karatzaferis A; Delladetsima I; Barbatis C; Moutsopoulos HM
J Rheumatol; 2008 Oct; 35(10):2012-6. PubMed ID: 18709690
[TBL] [Abstract][Full Text] [Related]
18. Does the diagnosis of primary biliary cirrhosis or autoimmune cholangitis depend on the 'phase' of the disease?
Kadokawa Y; Omagari K; Ohba K; Masuda J; Hazama H; Kinoshita H; Ohnita K; Mizuta Y; Tanioka H; Imanishi T; Kohno S
Liver Int; 2005 Apr; 25(2):317-24. PubMed ID: 15780056
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of antimitochondrial antibodies].
Rüegg R; Matter L; Schopfer K; Grob PJ
Schweiz Med Wochenschr; 1985 Mar; 115(9):290-6. PubMed ID: 3983600
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis.
Tanaka A; Nezu S; Uegaki S; Mikami M; Okuyama S; Kawamura N; Aiso M; Gershwin ME; Takahashi S; Selmi C; Takikawa H
Ann N Y Acad Sci; 2007 Jun; 1107():259-70. PubMed ID: 17804554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
